Literature DB >> 24311386

Exploring resource use and associated costs in end-of-life care for older people with dementia in residential care homes.

Sarah Amador1, Claire Goodman, Derek King, Yi Ting Ng, Natasha Elmore, Elspeth Mathie, Ina Machen, Martin Knapp.   

Abstract

OBJECTIVE: The goals of this study are to describe end-of-life care costs of older people with dementia (OPWD) residents in care homes (CHs) with no on-site nursing and evaluate the economic case for an intervention designed to improve end-of-life care for OPWD in CHs.
METHODS: Phase 1 tracked for a year, from March 2009, health services received by 133 OPWD in six residential CHs in the East of England. CH and resident characteristics were obtained through standardised assessment tools, interviews with CH managers and publicly available information from the independent regulator of social care services in England. Phase 2 used a modified Appreciative Inquiry intervention that ran for 6 months from January 2011, in three of the six CHs. Wilcoxon matched-pairs sign-rank tests were conducted to compare total cost and cost components during Phases 1 and 2 for those residents who had participated in both.
RESULTS: Costs for each resident in Phase 1 were about £2800 per month, including service, accommodation and medication. Resource use was associated with resident characteristics. The intervention was perceived as having a positive impact on working relationships between CHs and visiting health care practitioners. Following the intervention total service costs fell by 43%. Hospital care costs fell by 88%.
CONCLUSIONS: Results presented here represent early work in an under-researched area of care. Appreciative Inquiry appears to improve and change working relationships with promising outcomes, but more research is needed to test these findings further with larger samples and more robust controls.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Aged; Care homes; Costing; Dementia; End of life

Mesh:

Year:  2013        PMID: 24311386     DOI: 10.1002/gps.4061

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  5 in total

Review 1.  Improving living and dying for people with advanced dementia living in care homes: a realist review of Namaste Care and other multisensory interventions.

Authors:  Frances Bunn; Jennifer Lynch; Claire Goodman; Rachel Sharpe; Catherine Walshe; Nancy Preston; Katherine Froggatt
Journal:  BMC Geriatr       Date:  2018-12-06       Impact factor: 3.921

2.  Namaste Care in nursing care homes for people with advanced dementia: protocol for a feasibility randomised controlled trial.

Authors:  Katherine Froggatt; Shakil Patel; Guillermo Perez Algorta; Frances Bunn; Girvan Burnside; Joanna Coast; Lesley Dunleavy; Claire Goodman; Ben Hardwick; Julie Kinley; Nancy J Preston; Catherine Walshe
Journal:  BMJ Open       Date:  2018-11-25       Impact factor: 2.692

3.  End of life care interventions for people with dementia in care homes: addressing uncertainty within a framework for service delivery and evaluation.

Authors:  Claire Goodman; Katherine Froggatt; Sarah Amador; Elspeth Mathie; Andrea Mayrhofer
Journal:  BMC Palliat Care       Date:  2015-09-17       Impact factor: 3.234

Review 4.  Effective health care for older people living and dying in care homes: a realist review.

Authors:  Claire Goodman; Tom Dening; Adam L Gordon; Susan L Davies; Julienne Meyer; Finbarr C Martin; John R F Gladman; Clive Bowman; Christina Victor; Melanie Handley; Heather Gage; Steve Iliffe; Maria Zubair
Journal:  BMC Health Serv Res       Date:  2016-07-16       Impact factor: 2.655

5.  Evaluation of an Organisational Intervention to Promote Integrated Working between Health Services and Care Homes in the Delivery of End-of-Life Care for People with Dementia: Understanding the Change Process Using a Social Identity Approach.

Authors:  Sarah Amador; Claire Goodman; Elspeth Mathie; Caroline Nicholson
Journal:  Int J Integr Care       Date:  2016-06-03       Impact factor: 5.120

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.